IL6 and hepatocellular carcinoma: first demonstrated that intratumor human cluster of differentiation–positive (hCD14+) cells could produce IL-33 through DAMP/TLR4/activator protein 1, which increased IL-6 in other intratumor immune cells and activated JAK2/STAT3 signaling in HCC (146).